Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations by Dentsply Sirona Inc. ("Dentsply" or the "Company") (NASDAQ: XRAY), a manufacturer of professional dental products and technologies.
On May 10, 2022, before the market open, the Company filed a Form 12b-25, Notification of Late Filing ("Notice of Late Filing"), with the U.S. Securities and Exchange Commission disclosing that it would be unable to timely file its Form 10-Q for three months ended March 31, 2022.
In the Notice of Late Filing, the Company disclosed that "[i]n March 2022, the Audit and Finance Committee of the Company's Board of Directors (the 'Audit Committee') commenced an internal investigation of allegations regarding certain financial reporting matters submitted by current and former employees of the Company." The Notice of Late Filing stated that "[t]he Audit Committee is also investigating allegations that certain former and current members of senior management directed the Company's use of these incentives and other actions to achieve executive compensation targets in 2021."
On this news, shares of the Company were down $2.87 per share (a 7.3% decline) to close at $36.38 per share on May 10, 2022.
If you purchased Dentsply securities and sustained substantial losses, and would like to discuss your legal rights and/or options, please submit your information here.
Berman Tabacco is a national law firm representing institutions and individuals in lawsuits, seeking to recoup losses caused by corporate and board misconduct and violations of the securities and antitrust laws. The firm has offices in Boston, Massachusetts and San Francisco, California.
This notice may constitute attorney advertising.
Jay Eng, Esq.
One Liberty Square
Email: [email protected]
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/125588
This content is published on behalf of the above source. Please contact them directly for any concern related to the above.